DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis (Q38476763)

3 September 2017

DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis (English)

1 reference

3 September 2017

J Diebold

1

1 reference

3 September 2017

B Suchy

2

1 reference

3 September 2017

G B Baretton

3

1 reference

3 September 2017

S Blasenbreu

4

1 reference

3 September 2017

W Meier

5

1 reference

3 September 2017

M Schmidt

6

1 reference

3 September 2017

H Rabes

7

1 reference

3 September 2017

U Löhrs

8

1 reference

3 September 2017

1 November 1996

1 reference

3 September 2017

1 reference

3 September 2017

429

1 reference

3 September 2017

4-5

1 reference

3 September 2017

221-227

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00198337

3 September 2017

0 references

cites work

Molecular genetic detection of Xp21 muscular dystrophy carriers in Cyprus

1 reference

12 December 2020

Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction

1 reference

12 December 2020

Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators

1 reference

12 December 2020

Deoxyribonucleic acid ploidy in seminomas with and without syncytiotrophoblastic cells

1 reference

12 December 2020

p53 gene mutations and protein accumulation in human ovarian cancer

1 reference

12 December 2020

A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas

1 reference

12 December 2020

Gene amplification and tumor progression

1 reference

12 December 2020

Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.

1 reference

12 December 2020

bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

1 reference

12 December 2020

Protooncogene amplification and tumor ploidy in human ovarian neoplasms

1 reference

12 December 2020

c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression

1 reference

12 December 2020

DNA ploidy in epithelial ovarian cancer: a new independent prognostic factor?

1 reference

12 December 2020

Cancer. p53, guardian of the genome

1 reference

12 December 2020

The c-myc oncogene in tumor progression.

1 reference

12 December 2020

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

1 reference

12 December 2020

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

1 reference

12 December 2020

Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.

1 reference

12 December 2020

Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypes

1 reference

12 December 2020

c-myc amplification in ovarian cancer

1 reference

12 December 2020

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

12 December 2020

Overexpression and mutation of p53 in epithelial ovarian cancer

1 reference

12 December 2020

Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors

1 reference

12 December 2020

p53 accumulation in ovarian carcinomas and its prognostic implications

1 reference

12 December 2020

The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary

1 reference

12 December 2020

Flow cytometric evaluation of ovarian cancer

1 reference

12 December 2020

C-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas

1 reference

12 December 2020

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer

1 reference

12 December 2020

Use of DNA image cytometry in addition to flow cytometry for the study of patients with advanced ovarian cancer

1 reference

12 December 2020

Myc amplification: regulation of myc function

1 reference

12 December 2020

Amplification of protooncogenes in human ovarian carcinomas

1 reference

12 December 2020

A death in the life of p53

1 reference

12 December 2020

c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle

1 reference

12 December 2020

Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer

1 reference

12 December 2020

Prognostic significance of DNA content in epithelial ovarian cancer

1 reference

12 December 2020

Tumor ploidy as a major prognostic factor in advanced ovarian cancer

1 reference

12 December 2020

Flow cytometric analysis of DNA content in human ovarian cancers

1 reference

12 December 2020

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

1 reference

12 December 2020

DNA cytophotometry and prognosis in ovarian tumors of borderline malignancy. A clinicomorphologic study of 80 cases

1 reference

12 December 2020

Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction

1 reference

12 December 2020

Frequent allelic losses and mutations of the p53 gene in human ovarian cancer

1 reference

12 December 2020

Prognostic significance of the DNA content in renal cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00198337

1 reference

3 September 2017

1 reference